| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Viral Vaccines | 42 | 2020 | 7560 | 3.61 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 31 | 2020 | 8843 | 2.34 | Why? |
| Viral Envelope Proteins | 17 | 2019 | 3539 | 2.09 | Why? |
| Membrane Glycoproteins | 13 | 2012 | 2273 | 1.82 | Why? |
| Spike Glycoprotein, Coronavirus | 49 | 2021 | 37182 | 1.57 | Why? |
| Antibodies, Neutralizing | 41 | 2021 | 25288 | 1.51 | Why? |
| Vaccines, Subunit | 14 | 2020 | 1088 | 1.43 | Why? |
| Receptors, Virus | 19 | 2021 | 5659 | 1.19 | Why? |
| Mice, Inbred BALB C | 25 | 2020 | 5814 | 1.09 | Why? |
| Dipeptidyl Peptidase 4 | 11 | 2020 | 1061 | 1.08 | Why? |
| Zika Virus | 5 | 2019 | 1924 | 1.01 | Why? |
| SARS Virus | 21 | 2020 | 13021 | 1.01 | Why? |
| Zika Virus Infection | 5 | 2019 | 1920 | 0.90 | Why? |
| Mice | 38 | 2021 | 21357 | 0.82 | Why? |
| Severe Acute Respiratory Syndrome | 15 | 2020 | 12361 | 0.78 | Why? |
| Antibodies, Viral | 41 | 2021 | 51949 | 0.77 | Why? |
| Protein Structure, Tertiary | 12 | 2014 | 1565 | 0.76 | Why? |
| Animals | 73 | 2021 | 78931 | 0.76 | Why? |
| Receptor, Angiotensin, Type 2 | 1 | 2020 | 190 | 0.71 | Why? |
| Neutralization Tests | 16 | 2020 | 6698 | 0.70 | Why? |
| Virus Internalization | 14 | 2020 | 7921 | 0.70 | Why? |
| Dependovirus | 3 | 2008 | 272 | 0.69 | Why? |
| Coronaviridae | 2 | 2014 | 923 | 0.66 | Why? |
| Cross Protection | 2 | 2020 | 373 | 0.63 | Why? |
| Epitopes | 11 | 2020 | 4113 | 0.60 | Why? |
| Cross Reactions | 7 | 2020 | 4374 | 0.57 | Why? |
| Recombinant Proteins | 12 | 2020 | 3786 | 0.56 | Why? |
| Receptors, Fc | 2 | 2020 | 153 | 0.54 | Why? |
| Coronavirus Infections | 44 | 2020 | 253789 | 0.53 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2017 | 492 | 0.51 | Why? |
| Coronavirus | 12 | 2020 | 18339 | 0.50 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2017 | 511 | 0.49 | Why? |
| HIV Fusion Inhibitors | 3 | 2019 | 80 | 0.49 | Why? |
| Adjuvants, Immunologic | 6 | 2015 | 1709 | 0.46 | Why? |
| Peptides | 9 | 2019 | 2513 | 0.43 | Why? |
| Protein Binding | 16 | 2021 | 11430 | 0.42 | Why? |
| Binding Sites | 8 | 2020 | 6201 | 0.41 | Why? |
| Antibody Formation | 5 | 2013 | 4038 | 0.41 | Why? |
| Vaccines, Synthetic | 10 | 2020 | 3231 | 0.41 | Why? |
| Antibodies, Monoclonal | 9 | 2020 | 8041 | 0.40 | Why? |
| Coronaviridae Infections | 1 | 2014 | 442 | 0.40 | Why? |
| Single-Domain Antibodies | 3 | 2021 | 744 | 0.36 | Why? |
| Communicable Diseases, Emerging | 2 | 2020 | 2523 | 0.35 | Why? |
| HIV Envelope Protein gp41 | 3 | 2019 | 153 | 0.33 | Why? |
| Complement C5a | 2 | 2018 | 116 | 0.33 | Why? |
| Factor Xa | 1 | 2007 | 113 | 0.32 | Why? |
| Gene Expression | 5 | 2020 | 3332 | 0.32 | Why? |
| HEK293 Cells | 9 | 2021 | 8394 | 0.32 | Why? |
| RNA, Messenger | 2 | 2020 | 5131 | 0.32 | Why? |
| Cell Line | 15 | 2020 | 12040 | 0.32 | Why? |
| Protein Domains | 10 | 2021 | 6563 | 0.31 | Why? |
| Amino Acid Sequence | 9 | 2020 | 6049 | 0.30 | Why? |
| Disease Models, Animal | 11 | 2019 | 10998 | 0.29 | Why? |
| Chiroptera | 7 | 2020 | 3530 | 0.29 | Why? |
| Antiviral Agents | 13 | 2020 | 41703 | 0.28 | Why? |
| Antigens, Viral | 8 | 2020 | 6298 | 0.26 | Why? |
| Humans | 83 | 2021 | 930598 | 0.26 | Why? |
| Influenza Vaccines | 3 | 2017 | 2941 | 0.25 | Why? |
| Virus Activation | 1 | 2007 | 480 | 0.24 | Why? |
| Protein Interaction Domains and Motifs | 3 | 2020 | 2134 | 0.24 | Why? |
| Respiratory Tract Infections | 5 | 2020 | 6817 | 0.23 | Why? |
| Antibody Specificity | 3 | 2013 | 1328 | 0.22 | Why? |
| Drug Design | 5 | 2020 | 2627 | 0.22 | Why? |
| Plasmids | 2 | 2016 | 840 | 0.21 | Why? |
| HIV-1 | 5 | 2019 | 3365 | 0.20 | Why? |
| CHO Cells | 3 | 2018 | 831 | 0.20 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.20 | Why? |
| Models, Molecular | 6 | 2021 | 7616 | 0.20 | Why? |
| Cricetulus | 3 | 2018 | 936 | 0.20 | Why? |
| Palmitic Acid | 1 | 2019 | 28 | 0.20 | Why? |
| Viral Matrix Proteins | 1 | 2008 | 1243 | 0.20 | Why? |
| Sequence Alignment | 3 | 2020 | 2109 | 0.19 | Why? |
| Paraquat | 1 | 2018 | 15 | 0.19 | Why? |
| Serum | 1 | 2020 | 294 | 0.19 | Why? |
| Immunoglobulin Fc Fragments | 4 | 2018 | 691 | 0.19 | Why? |
| Hemiterpenes | 1 | 2017 | 1 | 0.19 | Why? |
| Protein Structure, Secondary | 3 | 2020 | 1077 | 0.19 | Why? |
| Herbicides | 1 | 2018 | 20 | 0.19 | Why? |
| Membrane Fusion | 2 | 2020 | 713 | 0.18 | Why? |
| Hevea | 1 | 2017 | 4 | 0.18 | Why? |
| Virus Replication | 9 | 2018 | 14331 | 0.18 | Why? |
| Viral Fusion Protein Inhibitors | 1 | 2019 | 88 | 0.18 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.18 | Why? |
| Adenovirus Infections, Human | 1 | 2020 | 145 | 0.18 | Why? |
| Mice, Transgenic | 7 | 2021 | 2739 | 0.18 | Why? |
| Genome, Plant | 1 | 2017 | 41 | 0.18 | Why? |
| Drug Discovery | 4 | 2017 | 3092 | 0.17 | Why? |
| Immunity, Mucosal | 2 | 2014 | 426 | 0.17 | Why? |
| Lipopeptides | 1 | 2020 | 229 | 0.17 | Why? |
| Virus Attachment | 2 | 2015 | 1259 | 0.17 | Why? |
| Immunity, Cellular | 3 | 2015 | 3614 | 0.17 | Why? |
| Genetic Vectors | 3 | 2018 | 1600 | 0.16 | Why? |
| Porcine epidemic diarrhea virus | 2 | 2016 | 1017 | 0.16 | Why? |
| V(D)J Recombination | 1 | 2015 | 16 | 0.16 | Why? |
| Cathepsin B | 1 | 2016 | 101 | 0.16 | Why? |
| Antibody-Dependent Enhancement | 1 | 2020 | 413 | 0.15 | Why? |
| Protein Conformation | 6 | 2021 | 4386 | 0.15 | Why? |
| Genetic Engineering | 1 | 2018 | 325 | 0.15 | Why? |
| Administration, Intranasal | 4 | 2020 | 1132 | 0.15 | Why? |
| Immunogenicity, Vaccine | 3 | 2020 | 4624 | 0.14 | Why? |
| Immunoglobulin G | 8 | 2018 | 21571 | 0.14 | Why? |
| T-Lymphocytes | 3 | 2018 | 6670 | 0.14 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.14 | Why? |
| Middle East | 3 | 2014 | 1418 | 0.14 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2015 | 283 | 0.14 | Why? |
| Crystallography, X-Ray | 4 | 2015 | 2689 | 0.14 | Why? |
| Complement Activation | 2 | 2018 | 949 | 0.14 | Why? |
| Cricetinae | 3 | 2017 | 3344 | 0.14 | Why? |
| Picornaviridae Infections | 1 | 2020 | 544 | 0.14 | Why? |
| Pulmonary Edema | 1 | 2018 | 430 | 0.13 | Why? |
| Protein Subunits | 1 | 2016 | 755 | 0.13 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.13 | Why? |
| Female | 27 | 2020 | 380317 | 0.13 | Why? |
| HIV Antibodies | 2 | 2017 | 776 | 0.13 | Why? |
| N-Acetylneuraminic Acid | 1 | 2015 | 198 | 0.13 | Why? |
| Peptide Fragments | 3 | 2017 | 2075 | 0.13 | Why? |
| CD13 Antigens | 1 | 2015 | 232 | 0.13 | Why? |
| Lysosomes | 1 | 2016 | 416 | 0.13 | Why? |
| Cathepsin L | 1 | 2016 | 566 | 0.13 | Why? |
| Onchocerca volvulus | 1 | 2012 | 23 | 0.12 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2017 | 415 | 0.12 | Why? |
| Kidney | 1 | 2007 | 3648 | 0.12 | Why? |
| Spleen | 3 | 2018 | 877 | 0.12 | Why? |
| Helminth Proteins | 1 | 2012 | 32 | 0.12 | Why? |
| Antigens, Helminth | 1 | 2012 | 54 | 0.12 | Why? |
| Epitope Mapping | 2 | 2014 | 1240 | 0.12 | Why? |
| Injections, Subcutaneous | 2 | 2014 | 647 | 0.12 | Why? |
| Virion | 2 | 2017 | 1444 | 0.12 | Why? |
| Vaccination | 7 | 2017 | 19050 | 0.11 | Why? |
| Camelus | 2 | 2019 | 1425 | 0.11 | Why? |
| Viral Structural Proteins | 1 | 2015 | 491 | 0.11 | Why? |
| Recombinant Fusion Proteins | 2 | 2015 | 919 | 0.11 | Why? |
| Immunization | 1 | 2020 | 2019 | 0.11 | Why? |
| Rabbits | 1 | 2014 | 1171 | 0.11 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.10 | Why? |
| Cryoelectron Microscopy | 1 | 2018 | 2372 | 0.10 | Why? |
| Orthomyxoviridae Infections | 1 | 2017 | 1001 | 0.10 | Why? |
| Mice, Inbred C57BL | 5 | 2021 | 5542 | 0.10 | Why? |
| Viral Fusion Proteins | 1 | 2014 | 399 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.10 | Why? |
| Insecta | 1 | 2009 | 122 | 0.10 | Why? |
| Immune Sera | 1 | 2013 | 884 | 0.09 | Why? |
| BALB 3T3 Cells | 1 | 2008 | 9 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.09 | Why? |
| Transfection | 1 | 2011 | 864 | 0.09 | Why? |
| Virus Inactivation | 1 | 2017 | 1139 | 0.09 | Why? |
| Anti-HIV Agents | 2 | 2017 | 2209 | 0.09 | Why? |
| Interleukin-4 | 1 | 2009 | 367 | 0.08 | Why? |
| Research | 1 | 2020 | 2115 | 0.08 | Why? |
| RNA, Small Interfering | 2 | 2009 | 817 | 0.08 | Why? |
| Immune Evasion | 1 | 2016 | 2081 | 0.08 | Why? |
| Viral Proteins | 4 | 2017 | 7370 | 0.08 | Why? |
| Immunization Schedule | 2 | 2017 | 1305 | 0.08 | Why? |
| Cloning, Molecular | 1 | 2009 | 1036 | 0.08 | Why? |
| RNA Interference | 1 | 2009 | 534 | 0.07 | Why? |
| Multiple Organ Failure | 1 | 2015 | 1724 | 0.07 | Why? |
| Drug Evaluation, Preclinical | 2 | 2015 | 3347 | 0.07 | Why? |
| Zoonoses | 1 | 2019 | 3034 | 0.07 | Why? |
| Ion Channels | 1 | 2006 | 167 | 0.07 | Why? |
| Flow Cytometry | 2 | 2017 | 2393 | 0.07 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.07 | Why? |
| Vero Cells | 4 | 2020 | 14117 | 0.07 | Why? |
| Microbial Sensitivity Tests | 3 | 2019 | 2886 | 0.07 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2008 | 552 | 0.06 | Why? |
| Swine | 3 | 2018 | 3352 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
| Lung | 6 | 2018 | 31049 | 0.06 | Why? |
| HeLa Cells | 1 | 2006 | 1303 | 0.06 | Why? |
| Molecular Sequence Data | 3 | 2015 | 3198 | 0.06 | Why? |
| Escherichia coli | 1 | 2009 | 1547 | 0.06 | Why? |
| Immunization, Passive | 1 | 2018 | 10067 | 0.06 | Why? |
| Nucleic Acid Amplification Techniques | 3 | 2020 | 3388 | 0.06 | Why? |
| Aluminum Hydroxide | 1 | 2020 | 133 | 0.05 | Why? |
| Chemokines | 2 | 2018 | 1095 | 0.05 | Why? |
| Drug Evaluation | 1 | 2020 | 100 | 0.05 | Why? |
| Proprotein Convertases | 1 | 2020 | 28 | 0.05 | Why? |
| Single Molecule Imaging | 1 | 2021 | 126 | 0.05 | Why? |
| Biomechanical Phenomena | 1 | 2021 | 291 | 0.05 | Why? |
| Pepsin A | 1 | 2019 | 20 | 0.05 | Why? |
| Immunization, Secondary | 1 | 2008 | 1649 | 0.05 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.05 | Why? |
| Respiratory Syncytial Virus Vaccines | 1 | 2020 | 104 | 0.05 | Why? |
| Circular Dichroism | 1 | 2019 | 154 | 0.05 | Why? |
| Mutation | 2 | 2016 | 12376 | 0.05 | Why? |
| Trypsin | 1 | 2020 | 209 | 0.05 | Why? |
| Cell Fusion | 1 | 2020 | 400 | 0.05 | Why? |
| Pregnancy, Animal | 1 | 2017 | 15 | 0.05 | Why? |
| Solubility | 1 | 2019 | 382 | 0.04 | Why? |
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 77 | 0.04 | Why? |
| Spodoptera | 1 | 2018 | 220 | 0.04 | Why? |
| Sf9 Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Urea | 1 | 2019 | 228 | 0.04 | Why? |
| Mice, Inbred ICR | 1 | 2017 | 242 | 0.04 | Why? |
| Immunologic Tests | 1 | 2020 | 445 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2017 | 335 | 0.04 | Why? |
| Genes, Immunoglobulin Heavy Chain | 1 | 2015 | 32 | 0.04 | Why? |
| Lethal Dose 50 | 1 | 2015 | 63 | 0.04 | Why? |
| Animal Structures | 1 | 2015 | 61 | 0.04 | Why? |
| Histocytochemistry | 1 | 2015 | 88 | 0.04 | Why? |
| Receptors, IgG | 1 | 2020 | 578 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 7868 | 0.04 | Why? |
| Immunoglobulin A | 1 | 2008 | 3567 | 0.04 | Why? |
| Biophysical Phenomena | 1 | 2015 | 78 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Phylogeny | 3 | 2020 | 13341 | 0.04 | Why? |
| Endopeptidase K | 1 | 2015 | 71 | 0.04 | Why? |
| Plant Proteins | 1 | 2017 | 194 | 0.04 | Why? |
| Flavivirus | 1 | 2017 | 182 | 0.04 | Why? |
| Complement Inactivating Agents | 1 | 2018 | 254 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Polysorbates | 1 | 2015 | 125 | 0.03 | Why? |
| Crystallization | 1 | 2015 | 331 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.03 | Why? |
| Vaccines | 1 | 2013 | 3692 | 0.03 | Why? |
| Clinical Trials as Topic | 3 | 2020 | 7330 | 0.03 | Why? |
| Pichia | 1 | 2013 | 42 | 0.03 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 9335 | 0.03 | Why? |
| Haplorhini | 1 | 2015 | 307 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 2 | 2019 | 3776 | 0.03 | Why? |
| Squalene | 1 | 2015 | 196 | 0.03 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.03 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.03 | Why? |
| Aluminum Compounds | 1 | 2012 | 17 | 0.03 | Why? |
| Macaca fascicularis | 1 | 2018 | 1009 | 0.03 | Why? |
| Immunoenzyme Techniques | 1 | 2015 | 448 | 0.03 | Why? |
| Lipid A | 1 | 2012 | 32 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2020 | 2219 | 0.03 | Why? |
| Mutagenesis, Site-Directed | 1 | 2014 | 449 | 0.03 | Why? |
| Polysaccharides | 1 | 2021 | 854 | 0.03 | Why? |
| Alum Compounds | 1 | 2013 | 210 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 13720 | 0.03 | Why? |
| Staining and Labeling | 1 | 2013 | 169 | 0.03 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4545 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2020 | 1562 | 0.03 | Why? |
| Drug Industry | 1 | 2020 | 689 | 0.03 | Why? |
| Phosphates | 1 | 2012 | 135 | 0.03 | Why? |
| Rats, Sprague-Dawley | 1 | 2015 | 987 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2020 | 1269 | 0.03 | Why? |
| Luciferases | 1 | 2013 | 378 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
| Hemagglutinins | 1 | 2012 | 143 | 0.03 | Why? |
| Proteolysis | 1 | 2015 | 751 | 0.03 | Why? |
| Peptide Library | 1 | 2014 | 564 | 0.03 | Why? |
| Hot Temperature | 1 | 2019 | 1299 | 0.03 | Why? |
| Liver | 2 | 2015 | 4007 | 0.03 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2008 | 5837 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.03 | Why? |
| Host Specificity | 1 | 2014 | 926 | 0.02 | Why? |
| Immunity, Humoral | 2 | 2015 | 4849 | 0.02 | Why? |
| Alleles | 1 | 2015 | 1557 | 0.02 | Why? |
| Glycosylation | 1 | 2013 | 1255 | 0.02 | Why? |
| Primates | 1 | 2012 | 584 | 0.02 | Why? |
| Antibody Affinity | 1 | 2014 | 1078 | 0.02 | Why? |
| China | 3 | 2020 | 50654 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.02 | Why? |
| Molecular Docking Simulation | 2 | 2014 | 6902 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Xenopus laevis | 1 | 2006 | 14 | 0.02 | Why? |
| Patch-Clamp Techniques | 1 | 2006 | 49 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| HIV Infections | 3 | 2019 | 11620 | 0.02 | Why? |
| Virulence | 1 | 2014 | 2172 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Viruses | 1 | 2020 | 2238 | 0.02 | Why? |
| Host-Pathogen Interactions | 2 | 2018 | 11041 | 0.02 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.02 | Why? |
| Oocytes | 1 | 2006 | 86 | 0.02 | Why? |
| Kinetics | 1 | 2014 | 3238 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2014 | 1672 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2013 | 27595 | 0.02 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.02 | Why? |
| Africa | 1 | 2013 | 2986 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Potassium | 1 | 2006 | 325 | 0.02 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.02 | Why? |
| Survival Analysis | 1 | 2015 | 7592 | 0.01 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.01 | Why? |
| Open Reading Frames | 1 | 2006 | 1898 | 0.01 | Why? |
| Brain | 1 | 2015 | 5133 | 0.01 | Why? |
| Europe | 1 | 2013 | 12702 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2010 | 17020 | 0.01 | Why? |
| Global Health | 1 | 2014 | 13911 | 0.01 | Why? |
| Treatment Outcome | 1 | 2015 | 51732 | 0.01 | Why? |
| Time Factors | 1 | 2010 | 31397 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2013 | 29620 | 0.00 | Why? |